About the Company
Actelion is a biopharmaceutical company founded in 1997, headquartered in Allschwil/Basel, Switzerland. Today with about 2?500 people in 29 countries we focus on discovery, development and marketing of original, innovative drugs for highly unmet medical needs. Our successfully marketed compounds are Tracleer® and Ventavis® for the treatment of pulmonary arterial hypertension and Zavesca®, the only approved oral treatment for Gaucher disease. Actelion shares are traded as part of the blue-chip SMI® (Swiss Market Index) since 2008. Actelion combines the innovation, entrepreneurial spirit and flexibility of biotech with the financial, risk management, regulatory and commercial discipline of a large pharmaceutical company. We have ambitious plans to keep improving and growing ? and are looking for people as innovative as ourselves.
Job Responsibilities
|
|